Latest News
Share this page

Latest News

This latest news is all about the App and your opportunity to get involved!!


Latest News

Latest News

If you have not already downloaded the App, click here to read about the App and to learn how to download it and how to use it.

For those of you already using the App, we need you to tell us about your experience. 

We are often told about negative patient experiences: e.g. under-dosing on Urso, liver biopsies, patients not being told their liver test results (even after asking!!), patients not being part of the discussion about second-line therapies, etc.  When we raise this, we face "yeah, but... where is your evidence?" replies, which is somewhat unhelpful.

So, we are asking you. You are our evidence!!  You live and breathe this every single day. You are the ones coming out of clinical appointments, sometimes deflated or feeling ignored, still not with the knowledge you seek.  So let us together collect the evidence. Let u use what we know, what we experience, how we live to improve the situation: not only for us, but for the generations to come.

So please, please, please fill in these surveys, use the app, become the answer.

The answer is out there. We have to ask the right people the right questions. You are the right people! We need your knowledge.

  • Collette's Christmas Message

    Collette's Christmas Message

    Posted: Dec 23rd, 2019

    In the last vlog of 2019, Collette delivers her Christmas message. Please click the following link to view: We hope you have a Merry Christmas and Happy and Prosperous 2020
  • Mail on Sunday artcile

    Mail on Sunday artcile

    Posted: Dec 17th, 2019

    PBC features in The Mail on Sunday. Thank you Pat Hagan and all contributors telling their stories. A special thanks to our Edinburgh volunteer Esther Davidson who also helps the PBC Foundation to provide free Support for Life to over...
  • CymaBay Seladelpar Drug Trial Update by Dr George Mells

    CymaBay Seladelpar Drug Trial Update by Dr George Mells

    Posted: Dec 3rd, 2019

    CymaBay Therapeutics, a drug company focussed on developing medications for liver diseases including primary biliary cholangitis (PBC), recently announced that it had stopped all studies of a potential new medication called Seladelpar....